PGY2 Oncology Pharmacy Residency at UH Cleveland Medical Center
Resident Research
| Year | Name | Project |
|---|---|---|
| 2024-25 | Alina Hung | Evaluation of Plerixafor in Autologous Hematopoietic Stem Cell Mobilization |
| 2024-25 | Lindsay Tomcsanyi | Incidence of Infusion-Related Reactions Following Subcutaneous Administration of Daratumumab |
| 2023-24 | Tiffany Chan | Lenvatinib Toxicity in Endometrial Cancer |
| 2023-24 | Jessica Sieg | Bisphosphonate Use in Hypercalcemia of Malignancy |
| Year | Name | Project |
|---|---|---|
| 2024-25 | Alina Hung | Efficacy of Ibrutinib, Ruxolitinib and/or Belumosudil without Concomitant Corticosteroids in the Treatment of Graft-Versus-Host Disease |
| 2024-25 | Lindsay Tomcsanyi | Outcomes After Standardization of Conditioning Regimens & Graft-Versus Host Disease Prophylaxis in MRD & MUD Allogeneic Stem Cell Transplants |
| 2023-24 | Tiffany Chan | Day 1, 3, 5 vs Day 1, 2, 3 intermediate to high-dose cytarabine for acute myeloid leukemia consolidation therapy in patients 60 years of age or greater |
| 2023-24 | Jessica Sieg | Tacrolimus Time in Therapeutic Range after Hematopoietic Stem Cell Transplant |